All Stories

  1. Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance
  2. Optical and Scanning Electron Microscopy Thrombus Findings in Patients with STEMI Undergoing Primary Versus Rescue PCI
  3. Novel Therapeutics for Familial Chylomicronemia Syndrome
  4. BIOMARCADORES INFLAMATÓRIOS NA ESTRATIFICAÇÃO DE RISCO E ACOMPANHAMENTO DOS PACIENTES: FOCO NAS ESTRATÉGIAS ANTI-INFLAMATÓRIAS
  5. Smaller Infarct Size with Ticagrelor vs. Clopidogrel in STEMI Patients: Insights from Cardiac MRI
  6. The phenotype of monocyte subtypes and expression of chemokine receptors in the Chronic Venous Insufficiency
  7. Advances and challenges in nanofiber production: techniques and applications in nanotechnology
  8. PARTICULARIDADES DA APRESENTAÇÃO CLÍNICA DAS SÍNDROMES CORONÁRIAS NA MULHER: DISSECÇÃO ESPONTÂNEA DA ARTÉRIA CORONÁRIA E AVANÇOS DIAGNÓSTICOS DA ANOCA, INOCA E MINOCA
  9. EFICÁCIA E SEGURANÇA DE LONGO PRAZO DA INCLISIRANA EM PACIENTES DE ALTO RISCO CARDIOVASCULAR E LDL-COLESTEROL ELEVADO (ORION-3): RESULTADOS DA EXTENSÃO ABERTA DE 4 ANOS DOS ESTUDOS ORION-1 E ORION-3
  10. Forty years of a Postgraduate Program in Cardiology at a Brazilian public university: indicators of its graduates
  11. OBESIDADE E DISLIPIDEMIA ATEROGÊNICA
  12. OBESIDADE, INFLAMAÇÃO E ATEROSCLEROSE
  13. Relação da Ascensão Matinal da Pressão Arterial com a Hipertrofia Ventricular Esquerda em Hipertensos Obesos
  14. Persistence of a proinflammatory status after treatment of the acute myocardial infarction
  15. FATORES DE RISCO NA MULHER: TRADICIONAIS E ESPECÍFICOS
  16. Os Pacientes de Baixo Risco Cardiovascular Poderiam Ser Melhor Estratificados?
  17. Inflammation in Cardiovascular Disease: Current Status and Future Perspectives
  18. Primary Prevention of Cardiovascular Disease at Community Clinics in the State of Sao Paulo, Brazil: Results from the Epidemiological Information Study of Communities
  19. Estratégia Farmacoinvasiva em Idosos até 75 Anos ou Não Idosos: Análise de Parâmetros Bioquímicos e de Ressonância Nuclear Magnética Cardíaca
  20. Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
  21. Triagem Direcionada da Hipercolesterolemia Familiar em 11 Pequenas Cidades Brasileiras: Uma Abordagem Eficaz para Detectar Agrupamentos de Indivíduos Afetados
  22. Macrófagos e Neovascularização na Neoaterosclerose Intra-Stent: um Fenótipo Inflamatório Acelerado por OCT com Implicações Terapêuticas
  23. Variabilidade da Pressão Arterial e do Risco Cardiovascular no ELSA-Brasil: Um Potencial Marcador Substituto para Predizer Mortalidade e Desfechos Cardiovasculares?
  24. Evaluation of pulse wave velocity and central systolic blood pressure in children and adolescents with chronic kidney disease
  25. Podemos Pré-Tratar Enxertos de Veia com Adiponectina para Melhorar sua Permeabilidade?
  26. Desempenho do Eletrocardiograma no Diagnóstico da Hipertrofia Ventricular Esquerda em Hipertensos Idosos e Muito Idosos
  27. Phytosterol consumption and markers of subclinical atherosclerosis: Cross-sectional results from ELSA-Brasil
  28. Pacientes Naïve Infectados por HIV Apresentam Disfunção Concomitante com Diminuição de Anticorpos Naturais contra Autoantígenos Derivados da Apolipoproteína B Definidos
  29. Ausência de Descenso da Pressão Arterial Detectada pela Monitorização Ambulatorial da Pressão Arterial em Pacientes com Doença de Chagas Aguda Transmitida por Via Oral
  30. Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Random...
  31. Capillary electrophoresis with dual diode array detection and tandem mass spectrometry to access cardiovascular biomarkers candidates in human urine: Trimethylamine-N-Oxide and l-carnitine
  32. Circulating microparticles and central blood pressure according to antihypertensive strategy
  33. High-intensity statin monotherapy versus moderate-intensity statin plus ezetimibe therapy: Effects on vascular biomarkers
  34. Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease
  35. Inflammatory environment and immune responses to oxidized LDL are linked to systolic and diastolic blood pressure levels in hypertensive subjects
  36. Endothelial Progenitor Cell Mobilization and Platelet Microparticle Release Are Influenced by Clopidogrel Plasma Levels in Stable Coronary Artery Disease
  37. Euterpe Oleracea (Açai) Modifies Sterol Metabolism and Attenuates Experimentally-Induced Atherosclerosis
  38. Sensibilidade do eletrocardiograma na hipertrofia ventricular de acordo com gênero e massa cardíaca
  39. Geometric patterns of left ventricular hypertrophy and electrocardiography
  40. Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy
  41. The role of soluble fiber intake in patients under highly effective lipid-lowering therapy
  42. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial
  43. Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits
  44. Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program
  45. Avaliação da hipertensão arterial resistente pela monitorização residencial da pressão arterial
  46. Phytosterols and phytosterolemia: gene–diet interactions
  47. Distrofia muscular de Duchenne: análise eletrocardiográfica de 131 pacientes
  48. Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event
  49. Early Increase in Autoantibodies Against Human Oxidized Low-Density Lipoprotein in Hypertensive Patients After Blood Pressure Control
  50. Ezetimibe, Oxidized Low Density Lipoprotein, Lp (a), and Dyslipidemia
  51. Estatinas y accidente cerebrovascular: posibles mecanismos de acción de la protección neurovascular
  52. Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
  53. I 003 Resident Peritoneal Inflammatory Cells are Pivotal in the Development of Experimental Atherosclerosis
  54. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation
  55. Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes
  56. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
  57. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
  58. Perfil glicometabólico inicial em pacientes com síndrome coronariana aguda e síndrome metabólica
  59. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
  60. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients
  61. LOW TITERS OF HUMAN ANTI-OXLDL AUTOANTIBODIES ARE ASSOCIATED WITH UNSTABLE CORONARY DISEASE
  62. METABOLIC EFFECTS OF ANTYHYPERTENSIVE AGENTS IN NORMOGLYCEMIC, NORMOLIPIDEMIC HYPERTENSIVE PATIENTS
  63. Massa ventricular e critérios eletrocardiográficos de hipertrofia: avaliação de um novo escore
  64. Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
  65. L 063 LIPID PROFILE AND CARDIOVASCULAR RISK IN A POPULATION FROM THE MARAJÓ ISLAND
  66. L 015 LOW TITERS OF HUMAN ANTIOXIDIZED LDL AUTOANTIBODIES ARE ASSOCIATED WITH UNSTABLE CORONARY DISEASE
  67. H 011 METABOLIC EFFECTS OF ANTYHYPERTENSIVE AGENTS IN NORMOGLYCEMIC, NORMOLIPIDEMIC HYPERTENSIVE PATIENTS
  68. IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
  69. One-Month Therapy with Simvastatin Restores Endothelial Function in Hypercholesterolemic Children and Adolescents
  70. Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis
  71. Tu-P9:360 Coronary risk assessment by carotid-radial pulse wave velocity
  72. We-P14:403 Drip paper-filtered and boiled and cotton-filtered coffee reduce lipid peroxidation and anthropometric parameters in primary hypercholesterolemia
  73. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL‐C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin
  74. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects
  75. High Glucose Levels Abolish Antiatherosclerotic Benefits of ACE Inhibition in Alloxan-Induced Diabetes in Rabbits
  76. T01-P-012 The D9N polymorphism of lipoprotein lipase gene is a marker for myocardial infarction in diabetics
  77. Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects
  78. Comparison between the effects of soy milk and non-fat cow milk on lipid profile and lipid peroxidation in patients with primary hypercholesterolemia
  79. Hydrochlorothiazide abolishes the anti‐atherosclerotic effect of quinapril
  80. Early Benefits of Pravastatin to Experimentally Induced Atherosclerosis
  81. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro
  82. In vivo vasoreactivity during neoendothelialization after coronary angioplasty in pigs
  83. Dietary magnesium improves endothelial dependent relaxation of balloon injured arteries in rats